雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Beta-interferon in the treatment of multiple sclerosis Takahiko SAIDA 1 1Department of Neurology, Utano National Hospital Keyword: 多発性硬化症 , インターフェロンベータ , IFNβ , 副作用 , 中和抗体 pp.191-197
Published Date 1997/4/10
DOI https://doi.org/10.11477/mf.1431900937
  • Abstract
  • Look Inside

Results of a double-blind, placebo-controlled study in ambulatory patients with relapsing-remitting MS showed that interferon beta-1b reduced the rate of exacerbations by one-third compared with placebo and limited new disease activity in the brain as evidenced by MRI. Interferon betalb, administered subcutaneously at a dosage of 8 million (M) IU every other day is indicated for the treatment of ambulatory patients with relapsing-remitting MS. The most common adverse effects include injection-site reactions and flu-like symptoms, which are generally manageable and usually abate after the first few months of treatment.


Copyright © 1997, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1243 印刷版ISSN 0001-8724 医学書院

関連文献

もっと見る

文献を共有